The Latest Cardiac and Vascular News
ZWICKAU, Germany, April 18, 2018 /PRNewswire/ — HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair. This approval will provide physicians the ability to remodel the leaflets of the mitral valve and reestablish proper coaptation. The CoAp Pro expands HeartStitch’s product line of cardiovascular […]
SANTA CRUZ, Calif., April 19, 2018 /PRNewswire/ — Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures, announced today that it has completed a Series B funding round totaling over $10 million. The funding includes $3 million in new […]
SEATTLE, April 19, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has been recognized as one of the Top 10 Cardio Vascular Device Companies of 2018 by MedTech Outlook Magazine, an industry periodical committed to covering the […]
ATLANTA, April 17, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 first quarter financial results will be released on Wednesday, May 2, 2018 after the market closes. On Thursday, May 3, 2018 the Company will hold a teleconference call and live webcast at 8:00 […]
ABBOTT PARK, Ill., April 18, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2018. First-quarter worldwide sales of $7.4 billion increased 16.7 percent on a reported basis and 6.9 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.23 in the first quarter. Adjusted diluted EPS from […]
VANCOUVER, April 17, 2018 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollment for the Phase 4 SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), in the post-authorization […]
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it closed a Series C financing totaling $20 million. This financing is designed to fund the Company through Pre-Market Approval (“PMA”) of the Tack Endovascular System for the treatment of post-angioplasty […]
PARIS–(BUSINESS WIRE)–LimFlow SA, developer of innovative, peripheral endovascular technology transforming the treatment of critical limb ischemia (CLI), today announced it has secured €27 million ($33.5 million) in an oversubscribed Series C financing. The round was led by Sofinnova Partners, with continued participation from existing round B investors Bpifrance, the French […]
DANVERS, Mass., April 13, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, May 3, 2018, the Company will release financial results for the fourth quarter of fiscal 2018. The Company will host a conference call to discuss the results on Thursday, May 3, 2018, at 8:00 a.m. EDT. […]
TUSTIN, Calif., April 12, 2018 /PRNewswire/ — Asahi Intecc USA, Inc. will begin direct sales of its coronary (PTCA) guide wires in the US. These guide wires are currently distributed by Abbott Vascular. As of July 1, 2018 the entire portfolio of Asahi PTCA guide wires will also be available directly from Asahi. All sales requests prior to July 1 should continue to be directed […]
